The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity (Q40929264)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 February 2016

Language	Label	Description	Also known as
English	The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity	scientific article published on 5 February 2016

Statements

scholarly article

1 reference

24 September 2017

The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity (English)

1 reference

24 September 2017

0 references

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Francesco Forconi

2

1 reference

24 September 2017

Daniel Catovsky

6

object named as

Daniel Catovsky

1 reference

24 September 2017

Peter W. Thomas

5

object named as

Peter Thomas

1 reference

24 September 2017

author name string

Zadie Davis

1

1 reference

24 September 2017

Anton Parker

3

1 reference

24 September 2017

Anne Gardiner

4

1 reference

24 September 2017

Matthew Rose-Zerilli

7

1 reference

24 September 2017

Jonathan C Strefford

8

1 reference

24 September 2017

David Oscier

9

1 reference

24 September 2017

language of work or name

0 references

publication date

5 February 2016

1 reference

24 September 2017

British Journal of Haematology

1 reference

24 September 2017

173

1 reference

24 September 2017

127-136

1 reference

24 September 2017

1

1 reference

24 September 2017

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Human autoantibody recognition of DNA

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutations

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

B-cell receptor signaling in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Non-coding recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13940

21 January 2018

Identifiers

10.1111/BJH.13940

1 reference

24 September 2017

1 reference

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40929264&oldid=1910845135"